[fam-] trastuzumab deruxtecan (DS-8201) - Daiichi Sankyo, AstraZeneca
DS-8201: PDUFA action date for HER2 positive metastatic breast cancer on April 29, 2020 (Daiichi Sankyo) - Nov 1, 2019 - Q2 FY 2019 Results 
PDUFA date
https://www.daiichisankyo.com/media_investors/investor_relations/ir_calendar/files/005454/FY2019Q2_Presentation%20Material.pdf
 
Nov 1, 2019
 
 
ccd5ce2a-b9ff-4eda-9d76-9a42c94b87c7.jpg